RORĪ³t allosteric inhibitor
Orally bioavailable in higher species
from HTS and ligand-based design
ACS Med. Chem. Lett. 11, 114-119
Merck, Boston, MA
“compound 25”-2
1 min read
RORĪ³t inhibitor from Merck (Merck ROR-gamma-t oral in vivo allosteric inhibitor)
Search By Structure
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- “compound 25”
- “compound 25”-2
- WF-47-JS03
- BMS-986260
- GNF2133
Molecules of the Month
2023
2022
2021
2020